Innovative Technology Immuneed's proprietary ID.Flow platform utilizes human blood donations to enhance preclinical safety and efficacy assessments, presenting an opportunity to collaborate with biotech and pharma companies seeking advanced non-animal testing solutions.
Recent Asset Sale The company's sale of its immunotherapy technology assets to Ultimovacs indicates a strategic shift, potentially opening doors for partnerships in immune system research and offering avenues to integrate complementary technologies.
Market Niche Operating in the research services industry with a focus on immune reactions, Immuneed serves a specialized segment that aligns with growing interests in personalized medicine and immune-modulating therapies, providing targeted sales opportunities.
Funding & Growth With recent funding of over $500K despite modest revenue, Immuneed is positioned for further development and collaboration, making it a viable partner for innovative research projects and early-stage biotech initiatives.
Strategic Location Based in Uppsala, Sweden, a hub for biotech innovation, the company is well-placed to engage with European research consortia and biotech clusters, facilitating regional and international sales and partnership opportunities.
$50M$100M
$1M$10M
$10B
$1M$10M
$10B
$1B$10BImmuneed uses 8 technology products and services including Varnish, Cybot, Webpack, and more. Explore Immuneed's tech stack below.
| Immuneed Email Formats | Percentage |
| First.Last@immuneed.com | 97% |
| First.Middle@immuneed.com | 3% |
Research ServicesUppsala, Sweden11-50 Employees
Our technology, ID.Flow, utilizes freshly donated human blood to help researchers better understand drug-induced immune reactions during non-clinical development. By improving the accuracy and relevance of safety and efficacy assessments, we reduce the need for animal studies and enhance the translatability of preclinical findings.
Company Overview
Funding & FinancialsImmuneed has raised a total of $504K of funding over 1 rounds. Their latest funding round was raised on Sep 13, 2016 in the amount of $504K.
Immuneed's revenue is estimated to be in the range of $1M
Funding & FinancialsImmuneed has raised a total of $504K of funding over 1 rounds. Their latest funding round was raised on Sep 13, 2016 in the amount of $504K.
Immuneed's revenue is estimated to be in the range of $1M
1-888-653-2347 
support@leadiq.com